CRYPTOLEPIS-SANGUINOLENTA - ANTIMUSCARINIC PROPERTIES OF CRYPTOLEPINE AND THE ALKALOID FRACTION AT M1, M2 AND M3 RECEPTORS

被引:33
作者
RAUWALD, HW [1 ]
KOBER, M [1 ]
MUTSCHLER, E [1 ]
LAMBRECHT, G [1 ]
机构
[1] UNIV FRANKFURT, DEPT PHARMACOL, W-6000 FRANKFURT, GERMANY
关键词
CRYPTOLEPIS-SANGUINOLENTA (LINDLEY) SCHLECHTER; PERIPLOCACEAE; CRYPTOLEPINE; ALKALOIDS; ANTIMUSCARINIC PROPERTIES; MUSCARINIC RECEPTOR SUBTYPES; N-METHYLATROPINE;
D O I
10.1055/s-2006-961531
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
From an ethanol extract of the roots of Cryptolepis sanguinolenta the alkaloid fraction and its main constituent cryptolepine were isolated by partitioning at pH 11 and column chromatography using silica gel and chloroform/methanol as eluent. Cryptolepine was identified mainly by EI-MS and H-1/C-13-NMR spectroscopy. Cryptolepine (3-30 muM) and the alkaloid fraction of Cryptolepis sanguinolenta (3-10 mug/ml) antagonized muscarinic effects at Ml receptors in rabbit vas deferens, M2 receptors in guinea-pig atria, and M3 receptors in guinea-pig ileum. The experiments, using N-methylatropine as reference drug, showed a significant antimuscarinic activity for both cryptolepine and the alkaloid fraction, but no appreciable receptor subtype selectivity (pA2 = 5.00-5.73). Cryptolepine was determined as the antimuscarinic principle of Cryptolepis sanguinolenta. At higher concentrations both materials displayed negative inotropic effects.
引用
收藏
页码:486 / 488
页数:3
相关论文
共 22 条
  • [1] H-1-NMR AND C-13-NMR ASSIGNMENTS OF CRYPTOLEPINE, A 3 - 4-BENZ-DELTA-CARBOLINE DERIVATIVE ISOLATED FROM CRYPTOLEPIS-SANGUINOLENTA
    ABLORDEPPEY, SY
    HUFFORD, CD
    BORNE, RF
    DWUMABADU, D
    [J]. PLANTA MEDICA, 1990, 56 (04) : 416 - 417
  • [2] STUDIES ON CRYPTOLEPINE .2. INHIBITION OF CARRAGEENAN INDUCED EDEMA BY CRYPTOLEPINE
    BAMGBOSE, SOA
    NOAMESI, BK
    [J]. PLANTA MEDICA, 1981, 41 (04) : 392 - 396
  • [3] BOAKYE YK, 1977, 3RD P S MED PLANTS N, P91
  • [4] STRUCTURE-ACTIVITY-RELATIONSHIPS OF SOME GALBULIMIMA ALKALOIDS RELATED TO HIMBACINE
    DARROCH, SA
    TAYLOR, WC
    CHOO, LK
    MITCHELSON, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (01) : 131 - 136
  • [5] CONSTITUENTS OF WEST-AFRICAN MEDICINAL-PLANTS .20. QUINDOLINE FROM CRYPTOLEPIS-SANGUINOLENTA
    DWUMABADU, D
    AYIM, JSK
    FIAGBE, NIY
    KNAPP, JE
    SCHIFF, PL
    SLATKIN, DJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (03) : 433 - 434
  • [6] PRESYNAPTIC MUSCARINIC RECEPTORS MEDIATING INHIBITION OF NEUROGENIC CONTRACTIONS IN RABBIT VAS-DEFERENS ARE OF THE GANGLIONIC M1-TYPE
    ELTZE, M
    GMELIN, G
    WESS, J
    STROHMANN, C
    TACKE, R
    MUTSCHLER, E
    LAMBRECHT, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 158 (03) : 233 - 242
  • [7] MUSCARINIC RECEPTOR SUBTYPES
    HULME, EC
    BIRDSALL, NJM
    BUCKLEY, NJ
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1990, 30 : 633 - 673
  • [8] AFFINITY PROFILES OF HEXAHYDRO-SILA-DIFENIDOL ANALOGS AT MUSCARINIC RECEPTOR SUBTYPES
    LAMBRECHT, G
    FEIFEL, R
    WAGNERRODER, M
    STROHMANN, C
    ZILCH, H
    TACKE, R
    WAELBROECK, M
    CHRISTOPHE, J
    BODDEKE, H
    MUTSCHLER, E
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 168 (01) : 71 - 80
  • [9] LEVINE RR, 1989, TRENDS PHARM SCI S, V10
  • [10] STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW ANALOGS OF ARECAIDINE PROPARGYL ESTER AT MUSCARINIC-M1 AND MUSCARINIC-M2 RECEPTOR SUBTYPES
    MOSER, U
    LAMBRECHT, G
    WAGNER, M
    WESS, J
    MUTSCHLER, E
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) : 319 - 324